Tracking recovery and quality of life after transcatheter heart valve replacement
Observes how people with aortic stenosis fare after a heart valve replaced through a catheter.
Key facts
- Who runs it
- Sheba Medical Center
- Where
- Jerusalem, Petah Tikva, Ramat Gan, and Tel Aviv, IsraelSee the 5 sites
- Trial code
- Registry title
- Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- Nov 2013
- Expected to end
- Nov 2030
- Type of study
- Observational
- Record updated
- 29 November 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults chosen to have a heart valve replaced through a thin tube (transcatheter), in the aortic or mitral valve. It follows how they do over time.
- Age
- 18 Years to 110 Years
- Sex
- All sexes can join.
- Disease stage
- People selected for transcatheter heart valve replacement, for example for aortic stenosis (narrowed aortic valve).
Main reasons for not taking part
- Not able to sign written informed consent
- Pregnancy
- Breastfeeding
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Subject selected for transcatheter heart valve replacement
- Signed informed consent to participate in the study
Who cannot take part
- Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test)
- Inability to sign written informed consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 110 years old?
Where in Israel
- Hadassah medical CenterJerusalem, IsraelContact: Gideon PerlmanTaking people
- Shaarei Zedek amedical CenterJerusalem, IsraelContact: Elad AsherTaking people
- Rabin Medical CenterPetah Tikva, IsraelContact: Alon BarsheshetTaking people
- Sheba medical centerRamat Gan, IsraelContact: Israel Barbash, MDTaking people
- Tel Aviv Medical CenterTel Aviv, IsraelContact: Arik SteinvilTaking people
About the trial
What the trial wants to find out
The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
- Plain-language title
- Tracking recovery and quality of life after transcatheter heart valve replacementGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT02023060, who can take part
- Record updated
- 29 November 2023